AlphaCrest Capital Management’s STAAR Surgical STAA Stock Holding History

AlphaCrest Capital Management’s Portfolio STAA Stock Details STAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-16,583	Closed	-$1.17M	–	994
2022 Q3	$1.17M	Buy	16,583 +12,783	+336%	+$1.09M	0.07%	512
2022 Q2	$270K	Buy	+3,800	New	+$245K	0.01%	1143
2022 Q1	–	Sell	-10,349	Closed	-$945K	–	1403
2021 Q4	$945K	Buy	10,349 +8,749	+547%	+$939K	0.04%	825
2021 Q3	$206K	Sell	1,600 -800	-33%	-$112K	0.01%	1209
2021 Q2	$366K	Buy	+2,400	New	+$316K	0.02%	1058
2020 Q2	–	Sell	-8,987	Closed	-$290K	–	1106
2020 Q1	$290K	Sell	8,987 -17,200	-66%	-$580K	0.04%	805
2019 Q4	$921K	Sell	26,187 -2,313	-8%	-$76.3K	0.08%	400
2019 Q3	$735K	Buy	+28,500	New	+$866K	0.04%	719

Other funds holding STAA

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

EFM

E Fund Management Guangzhou, China $3.37B AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

AlphaCrest Capital Management's STAA Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of STAAR Surgical (STAA) in Q4 2022, closing a stake of 16,583 shares — an estimated $1.17M sold.

AlphaCrest Capital Management first reported a position in STAA in Q3 2019 and held it in 8 quarters. The position peaked at $1.17M in Q3 2022. 275 funds tracked by Wall St. Rank hold STAA as of Q4 2022.

AlphaCrest Capital Management reported no remaining STAAR Surgical position as of Q4 2022 after selling out during the quarter.
AlphaCrest Capital Management sold 16,583 STAAR Surgical shares in Q4 2022, an estimated $1.17M.
AlphaCrest Capital Management first reported a position in STAAR Surgical in Q3 2019 and held it in 8 quarters.
AlphaCrest Capital Management's STAAR Surgical position peaked at $1.17M in Q3 2022.
275 funds tracked by Wall St. Rank held STAAR Surgical as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.